Immunogenic cell stress and death

被引:0
|
作者
Guido Kroemer
Claudia Galassi
Laurence Zitvogel
Lorenzo Galluzzi
机构
[1] Equipe labellisée par la Ligue contre le cancer,
[2] Centre de Recherche des Cordeliers,undefined
[3] INSERM U1138,undefined
[4] Sorbonne Université,undefined
[5] Université de Paris,undefined
[6] Institut Universitaire de France,undefined
[7] Metabolomics and Cell Biology Platforms,undefined
[8] Gustave Roussy Cancer Center,undefined
[9] Pôle de Biologie,undefined
[10] Hôpital Européen Georges Pompidou,undefined
[11] AP-HP,undefined
[12] Department of Radiation Oncology,undefined
[13] Weill Cornell Medical College,undefined
[14] Gustave Roussy Comprehensive Cancer Institute,undefined
[15] Université Paris Saclay,undefined
[16] Faculty of Medicine,undefined
[17] INSERM U1015,undefined
[18] Equipe labellisée par la Ligue contre le cancer,undefined
[19] Center of Clinical Investigations in Biotherapies of Cancer (CICBT) BIOTHERIS,undefined
[20] Sandra and Edward Meyer Cancer Center,undefined
[21] Caryl and Israel Englander Institute for Precision Medicine,undefined
来源
Nature Immunology | 2022年 / 23卷
关键词
D O I
暂无
中图分类号
学科分类号
摘要
Dying mammalian cells emit numerous signals that interact with the host to dictate the immunological correlates of cellular stress and death. In the absence of reactive antigenic determinants (which is generally the case for healthy cells), such signals may drive inflammation but cannot engage adaptive immunity. Conversely, when cells exhibit sufficient antigenicity, as in the case of infected or malignant cells, their death can culminate with adaptive immune responses that are executed by cytotoxic T lymphocytes and elicit immunological memory. Suggesting a key role for immunogenic cell death (ICD) in immunosurveillance, both pathogens and cancer cells evolved strategies to prevent the recognition of cell death as immunogenic. Intriguingly, normal cells succumbing to conditions that promote the formation of post-translational neoantigens (for example, oxidative stress) can also drive at least some degree of antigen-specific immunity, pointing to a novel implication of ICD in the etiology of non-infectious, non-malignant disorders linked to autoreactivity.
引用
收藏
页码:487 / 500
页数:13
相关论文
共 50 条
  • [31] Natural compound inducers of immunogenic cell death
    Marc Diederich
    Archives of Pharmacal Research, 2019, 42 : 629 - 645
  • [32] Immunogenic Cell Death and Immunotherapy of Multiple Myeloma
    Serrano-del Valle, Alfonso
    Anel, Alberto
    Naval, Javier
    Marzo, Isabel
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2019, 7
  • [33] Anticancer metal drugs and immunogenic cell death
    Terenzi, Alessio
    Pirker, Christine
    Keppler, Bernhard K.
    Berger, Walter
    JOURNAL OF INORGANIC BIOCHEMISTRY, 2016, 165 : 71 - 79
  • [34] Targeting immunogenic cell death for glioma immunotherapy
    Mishchenko, Tatiana A.
    Turubanova, Victoria D.
    Gorshkova, Ekaterina N.
    Krysko, Olga
    V. Vedunova, Maria
    V. Krysko, Dmitri
    TRENDS IN CANCER, 2024, 10 (01): : 8 - 11
  • [35] Systems biology of immunogenic cell death in melanoma
    Rufo, N.
    Sauter, T.
    Marine, J. C.
    Garg, A. D.
    Agostinis, P.
    EUROPEAN JOURNAL OF CANCER, 2016, 61 : S174 - S175
  • [36] Immunogenic cell death in cancer and infectious disease
    Galluzzi, Lorenzo
    Buque, Aitziber
    Kepp, Oliver
    Zitvogel, Laurence
    Kroemer, Guido
    NATURE REVIEWS IMMUNOLOGY, 2017, 17 (02) : 97 - 111
  • [37] The inducers of immunogenic cell death for tumor immunotherapy
    Li, Xiuying
    TUMORI JOURNAL, 2018, 104 (01): : 1 - 8
  • [38] Advances in Immunogenic Cell Death for Cancer Immunotherapy
    Ding, Dan
    Jiang, Xiqun
    SMALL METHODS, 2023, 7 (05)
  • [39] Dynamical Boolean Modeling of Immunogenic Cell Death
    Checcoli, Andrea
    Pol, Jonathan G.
    Naldi, Aurelien
    Noel, Vincent
    Barillot, Emmanuel
    Kroemer, Guido
    Thieffry, Denis
    Calzone, Laurence
    Stoll, Gautier
    FRONTIERS IN PHYSIOLOGY, 2020, 11
  • [40] Natural modulators of the hallmarks of immunogenic cell death
    Radogna, Flavia
    Dicato, Mario
    Diederich, Marc
    BIOCHEMICAL PHARMACOLOGY, 2019, 162 : 55 - 70